Table 1 Trial participants and community patients with each index condition
Index condition | Trials | Trial participants | Community-based sample |
|---|---|---|---|
Cardiometabolic | |||
 Type 2 diabetes mellitus | 21 | 23,750 | 82,473 |
 Atrial fibrillation | 1 | 18,033 | 43,330 |
 Hypertension | 8 | 5151 | 310,691 |
 Thromboembolism | 4 | 9362 | 9162 |
Respiratory | |||
 Asthma | 4 | 1623 | 191,160 |
 COPD | 7 | 5256 | 57,378 |
 Pulmonary fibrosis | 2 | 1063 | 1465 |
 Pulmonary hypertension | 1 | 406 | 759 |
Inflammatory | |||
 Axial spondyloarthritis | 2 | 458 | 1982 |
 Inflammatory bowel disease | 12 | 9241 | 12,514 |
 Psoriasis | 7 | 7568 | 52,810 |
 Psoriatic arthritis | 3 | 1331 | 3523 |
 Rheumatoid arthritis | 11 | 7662 | 13,809 |
 Systemic lupus erythematosus | 2 | 1693 | 1033 |
Musculoskeletal | |||
 Osteoarthritis | 1 | 1320 | 124,521 |
 Osteoporosis | 7 | 14,497 | 38,212 |
Neurological | |||
 Dementia | 7 | 6253 | 13,871 |
 Migraine | 5 | 3069 | 19,562 |
 Parkinson’s disease | 3 | 1368 | 4727 |
 Restless legs syndrome | 2 | 676 | 11,480 |
Urological | |||
 Benign prostatic hyperplasia | 5 | 2210 | 19,906 |
 Erectile dysfunction | 1 | 606 | 65,736 |